BT
Bhaskar Tripathi
About Bhaskar Tripathi
Data last updated:
Bhaskar Tripathi is a Director at Synaxia Lifesciences Private Limited (since 2024) and Director at Macprab Lifesciences Private Limited (since 2026). The companies operate in Pharma. The largest current company by reported revenue is Synaxia Lifesciences Private Limited at ₹7.3 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Aug 2024 | 2023 | ₹7.3 Lakh (FY 2025) | Active | |
| Director | 10 Jul 2026 | 2026 | Active |
Board colleagues of Bhaskar Tripathi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mandaabi Mishra | 10545148 | Synaxia Lifesciences Private Limited | Director |
| Reeta Kumari | 10353980 | Synaxia Lifesciences Private Limited | Director |
| Shravan Kumar | 11817316 | Macprab Lifesciences Private Limited | Director |
| Vikas Mishra | 11817317 | Macprab Lifesciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhaskar Tripathi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhaskar Tripathi
Bhaskar Tripathi currently holds 2 directorships: Synaxia Lifesciences Private Limited (Director, since 16 Aug 2024, revenue ₹7.3 Lakh (FY 2025)); Macprab Lifesciences Private Limited (Director, since 10 Jul 2026).
Bhaskar Tripathi was first appointed on 16 Aug 2024 as Director at Synaxia Lifesciences Private Limited. The most recent appointment on record is 10 Jul 2026 at Macprab Lifesciences Private Limited.
The current boards of Bhaskar Tripathi's companies include Mandaabi Mishra (Synaxia Lifesciences Private Limited), Reeta Kumari (Synaxia Lifesciences Private Limited), Shravan Kumar (Macprab Lifesciences Private Limited), Vikas Mishra (Macprab Lifesciences Private Limited).